by Christine Stackhouse | Oct 20, 2023
On October 20, 2023, Partner Paul Tuchmann was quoted in the Business Insider article titled, “Sam Bankman-Fried has less than a week to decide if he’ll testify in his trial. If he lies, he could get a longer prison sentence.” In regards to...
by Kelly Sweeney | Oct 17, 2023
Wiggin and Dana recently represented Notable Labs, Inc. (Notable), a clinical stage therapeutics platform company developing predictive precision medicines for cancer patients, in its merger with VBL Therapeutics (Nasdaq: VBLT) and associated financing transaction....
by Christine Stackhouse | Oct 16, 2023
On October 10-13, 2023, Partner Paul Tuchmann was quoted in Law360 and The New York Times regarding Sam Bankman-Fried’s criminal fraud trial in Manhattan. In the October 13 Law360 article titled, “Bankman-Fried Notches Small...
by Kelly Sweeney | Oct 10, 2023
Wiggin and Dana is proud to announce that Partners Joseph Casino and Michael Kasdan and Consulting Counsel Takao Saito have been named as world-leading IP Strategists in the 2023 edition of the IAM Strategy 300 – The World’s Leading IP...
by Christine Stackhouse | Oct 10, 2023
On October 10, 2023, Partner Paul Tuchmann was quoted in The New York Times article titled, “‘Don’t Do That Again’: Sam Bankman-Fried’s Lawyers Under Fire From Judge.” The article discusses Sam Bankman-Fried’s criminal trial in the Federal District Court...
